Article Details

Eyeing $600M in peak sales, Scynexis preps ambitious launch for antifungal Brexafemme

Retrieved on: 2021-06-30 13:52:30

Tags for this article:

Click the tags to see associated articles and topics

Eyeing $600M in peak sales, Scynexis preps ambitious launch for antifungal Brexafemme. View article details on hiswai:

Excerpt

RELATED: Merck women's health spinoff Organon's promise to women? ... Of more than 1,000 healthcare practitioners Scynexis questioned in a ...

Article found on: www.fiercepharma.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up